CoChat

Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.

Overview

Integrity signals

Registry

Crossref · 10.1038/ng771

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

Items 101–200 of 296

Metadata

Authors
Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., Albertson, D. G., Pinkel, D., Collins, C., Hanahan, D., & Gray, J. W.
Affiliations
University of California, San Francisco (US)
Corresponding author
Gray, Joe W.
Venue
Nature Genetics
Published
2001-11-05
Volume
29
Issue
4
Pages
459-464
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W1520880567
Cited by
294
References
26
Citations by year
2024: 6 · 2023: 1 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 10 · 2013: 3 · 2012: 5
FWCI
15.83
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca078601-02)
  • U.S. Public Health Service
  • University of California, San Francisco
  • National Cancer Institute (CA82103, R37-CA45234, CA78601, P30CA082103, R37CA045234)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
SV40 T antigen, loss of heterozygosity, chromosome 9, chromosome 16, copy number alterations, array comparative genomic hybridization, tumor suppressor, oncogenes, CYP24, STMN1, p27, FSTL1, genetic background, irradiation, mouse tumor model
MeSH terms
Animals, Base Sequence, Humans, Islets of Langerhans, Mice, Transgenic, Nucleic Acid Hybridization, Pancreatic Neoplasms, Genome, DNA Primers, Loss of Heterozygosity, Oligonucleotide Array Sequence Analysis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.